MoonLake Immunotherapeutics (MLTX) Property, Plant & Equipment (Net) (2021 - 2026)

MoonLake Immunotherapeutics (MLTX) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 642,333.36
2 Nanobiotix 1,924.26 Bn 1,924.20 Bn - 5.32 Mn
3 Akari Therapeutics 975.59 Bn 975.59 Bn - -
4 BeOne Medicines 471.47 Bn 466.67 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.76 Bn 114.52 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.90 Bn 61.15 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.83 Bn 62.83 Bn - -
8 Argenx Se 55.77 Bn 50.59 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.45 Bn 37.45 Bn - 31.48 Mn
10 MoonLake Immunotherapeutics 1.42 Bn 1.06 Bn - 532,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 532,000.00
Mar 31, 2026 532,000.00
Dec 31, 2025 577,000.00
Dec 31, 2025 577,000.00
Sep 30, 2025 622,000.00
Sep 30, 2025 622,000.00
Jun 30, 2025 667,000.00
Jun 30, 2025 667,000.00
Mar 31, 2025 711,000.00
Mar 31, 2025 711,000.00
Dec 31, 2024 722,000.00
Dec 31, 2024 722,000.00
Sep 30, 2024 581,378.00
Sep 30, 2024 581,378.00
Jun 30, 2024 481,705.00
Jun 30, 2024 481,705.00
Mar 31, 2024 509,816.00
Mar 31, 2024 509,816.00
Dec 31, 2023 320,865.00
Dec 31, 2023 320,865.00